Results 191 to 200 of about 458,298 (264)
Healthcare professionals show high AI enthusiasm but limited knowledge: A cross-sectional study. [PDF]
Abedin N, Hahn P, Zeuzem S, Dultz G.
europepmc +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
Co-Designing a Care Pathway for Healthcare Professionals to Recognise and Respond to Human Trafficking Victims in Emergency Departments. [PDF]
Rooy LV, Filmalter CJ.
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
An evaluation of DeepSeek and healthcare professionals' Q&A capabilities in improving patient-family satisfaction in the ICU. [PDF]
Li M, Li RY, Lai WJ, Yang FL, Liu CB.
europepmc +1 more source
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk +5 more
wiley +1 more source
Misconceptions About Obesity and Weight Stigma in Brazilian Healthcare Professionals. [PDF]
Sozza PV +6 more
europepmc +1 more source
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang +6 more
wiley +1 more source
South Korea's Artificial Intelligence Framework Act: A Guide for Healthcare Professionals. [PDF]
Park SH, Lee WB, Yang DH.
europepmc +1 more source

